Research Paper Volume 13, Issue 8 pp 11411—11432

Investigating the mechanisms of Modified Xiaoyaosan (tiaogan-liqi prescription) in suppressing the progression of atherosclerosis, by means of integrative pharmacology and experimental validation


Figure 2. Acquirement of the key targets between TGLQ putative targets and AS therapeutic targets through network analysis. (A) Venn diagram of common targets of TGLQ and AS; (B) Acquirement of the 63 key targets between TGLQ and AS by network topological analysis.